Health Care/Hospital

CPHI & PMEC Shenzhen 2024: Fostering New Opportunities in Asia and China's Greater Bay Area

SHANGHAI, July 15, 2024 /PRNewswire/ -- CPHI & PMEC China 2024 concluded in June with an exceptional turnout of visitors, setting a new attendance record. Notably, the number of international visitors grew to 11,563, and professionals from the end-to-end pharmaceutical supply chain made meaningfu...

2024-07-15 13:59 1776

Everest Medicines Announces Positive Topline Results from Maintenance Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderately-to-Severely Active Ulcerative Colitis

SHANGHAI, July 15, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced positive topline data results of the ...

2024-07-15 13:44 1854

Basecare Medical (2170. HK) revenue growth exceeds 50% in 2024H1

SUZHOU, China , July 15, 2024 /PRNewswire/ -- Basecare Medical (2170. HK) released an unaudited interim performance forecast onJuly 12th, stating that the company's revenue for the first half of the year was approximatelyRMB 127 million to RMB 138 million, an increase of approximately 49% to 62% ...

2024-07-15 12:17 3224

Nona Biosciences Enters into Collaboration Agreement with Alaya.bio to Advance CAR-T Cell Therapy

CAMBRIDGE, Mass., July 14, 2024 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody discovery through preclinical research, announced today that it has entered into a collaboration a...

2024-07-15 10:12 1218

Vaisala Enhances Rechargeable Battery Manufacturing with Fast-Response Dew Point Measurements

VANTAA, Finland, July 15, 2024 /PRNewswire/ -- As the world transitions to electrification and green energy, the demand for more powerful and safer rechargeable batteries—such as lithium-ion, sodium-ion, and solid-state—is rapidly growing. Vaisala, a global leader in measurement instruments and ...

2024-07-15 09:05 1934

Physta® Tongkat Ali: Breakthrough Antiviral Study Reinforces Immune-Boosting & Healthy Ageing Benefits

KUALA LUMPUR, Malaysia, July 15, 2024 /PRNewswire/ -- In a significant breakthrough for the nutraceutical industry, Physta® Tongkat Ali, a proprietary extract of the traditional herbEurycoma longifolia from Biotropics Malaysia, has been spotlighted in a recently published study for its potent ant...

2024-07-15 08:00 7741

Faith In Young Champions: Hisense Partners with UEFA Foundation to Bring the Beautiful Game to Hospitalized Children

QINGDAO, China, July 15, 2024 /PRNewswire/ -- During the EURO 2024 tournament, the global home appliance and consumer electronics brand Hisense and the UEFA Foundation jointly launched "Faith In Young Champions," a public welfare initiative. Innovative robots powered by Hisense enabled hospitaliz...

2024-07-15 07:53 3828

Nano Labs Announces Receipt of Deficiency Letters from Nasdaq

HANGZHOU, China, July 12, 2024 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or "Nano Labs"), a leading fabless integrated circuit design company and product solution provider in China, today announced that it received a notification letter datedJuly 11, 2024 (the "Deficiency Le...

2024-07-13 04:30 5885

Qilian International Holding Group Ltd Regained Compliance with Nasdaq's Minimum Bid Price Rule

CHENGDU, China, July 12, 2024 /PRNewswire/ -- Qilian International Holding Group Limited (NASDAQ: QLI) ("Qilian" or the "Company"), aChina-based pharmaceutical and chemical products manufacturer, today announced that onJuly 10, 2024, NASDAQ notified the Company that it has determined that for the...

2024-07-12 20:30 6171

Senhwa Biosciences Clinical Data Abstract of Pidnarulex Accepted for Presentation at 2024 ESMO Congress

TAIPEI and SAN DIEGO, July 12, 2024 /PRNewswire/ -- Senhwa Biosciences' new drug Pidnarulex (CX-5461) has demonstrated efficacy in treating various solid tumors with BRCA2 or PALB2 gene defects. The abstract of this clinical trial has been selected for presentation at the 2024 European Society fo...

2024-07-12 19:00 4412

Shenzhen Hosts the 2nd AGP&DTx Summit Forum: Advancing Digital Therapeutics in Diabetes Management

SHENZHEN, China, July 12, 2024 /PRNewswire/ -- On July 5th, the 2nd Ambulatory Glucose Profile (AGP) & Digital Therapeutics (DTx), led by the National Innovation Center for Advanced Medical Devices, sponsored by China AGP and DTx Digital Therapeutics R&D Center ("R&D Center"), co-sponsored by She...

2024-07-12 17:09 3839

MGI Tech Launches DNBSEQ-G400RS FluoXpert in the APAC Region at Medlab Asia & Asia Health 2024

BANGKOK, July 12, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today launched DNBSEQ-G400RS FluoXpert in the APAC region and opened early access to the platform at Medlab Asia & Asia Health 2024...

2024-07-12 16:57 3405

Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, July 12, 2024 /PRNewswire/ -- Sirnaomics Ltd.(the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, an...

2024-07-12 16:53 4283

Smartee Denti-Technology Debuts Themed Airplane with Spring Airlines

SHANGHAI, July 12, 2024 /PRNewswire/ -- Smartee Denti-Technology, in partnership with Spring Airlines, unveiled its inaugural themed airplane at Shanghai Hongqiao International Airport. The event was part of Smartee's 20th-anniversary celebrations.

2024-07-12 15:26 1891

Allianz Partners supports Paris 2024 with medical assistance and repatriation services

The 155,000 athletes, volunteers, and members of the Olympic and Paralympic Family will benefit from Allianz Partners' medical assistance and repatriation services during the Olympic and Paralympic Games Paris 2024. SINGAPORE, July 12, 2024 /PRNewswire/ -- Allianz Partners, a world leader in ass...

2024-07-12 07:00 16788

CONCORD MEDICAL ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE

BEIJING, July 11, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that it plans to change the ratio of its American d...

2024-07-12 04:00 3817

Medit Appoints Han Ryu as CEO, Focusing on Customer-Centric Innovation

SEOUL, South Korea, July 11, 2024 /PRNewswire/ -- Medit, a global leader in dental 3D scanners and digital dentistry solutions, has appointedHan Ryu as its new CEO. Ryu brings with him over three decades of senior management experience in global medical device and healthcare companies, including ...

2024-07-11 21:00 2421

CUHK identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders

Pilot clinical study shows modulation of gut microbiome alleviates anxiety symptoms  HONG KONG, July 11, 2024 /PRNewswire/ -- The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has conducted a large cohort study among 1,627 children with and without autism spectrum di...

2024-07-11 20:55 2566

Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham

* Beckham becomes a strategic investor in Prenetics * Beckham and Prenetics are co-founding partners for IM8, a new health and wellness brand LOS ANGELES, July 11, 2024 /PRNewswire/ -- Prenetics, (NASDAQ: PRE) a leading health sciences company, is proud to announce that former international...

2024-07-11 20:48 2960

First Patient Dosed in Phase I Clinical Trial of YOLT-201

SHANGHAI, July 11, 2024 /PRNewswire/ -- YolTech Therapeutics, a biotech company developing in vivo gene editing therapies to treat rare genetic diseases, announced today the successful enrollment of the first patient in the Phase I clinical trial of YOLT-201, its independently developed in vivo g...

2024-07-11 20:11 1746
1 ... 61626364656667 ... 847

Week's Top Stories